We are live on ! Find out more
BIVIW

BioVie Inc Warrant

8 hedge funds and large institutions have $734K invested in BioVie Inc Warrant in 2025 Q3 according to their latest regulatory filings, with 8 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

406.18% more ownership

Funds ownership: 0%406.18% (+406%)

Holders
8
Holders Change
+8
Holders Change %
% of All Funds
0.1%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
DC
1
Diametric Capital
Massachusetts
$345K +$305K +750,000 New
PCM
2
Prelude Capital Management
New York
$132K +$119K +293,436 New
WAM
3
Warberg Asset Management
Illinois
$125K +$115K +281,483 New
MA
4
MYDA Advisors
New York
$76.3K +$71.2K +175,000 New
HCM
5
Heights Capital Management
California
$41.4K +$36.6K +90,000 New
Cerity Partners
6
Cerity Partners
New York
$8.28K +$8.18K +20,101 New
TSS
7
Two Sigma Securities
New York
$5.65K +$5.58K +13,710 New
UBS Group
8
UBS Group
Switzerland
$412 +$407 +1,000 New

BIVIW Hedge Fund Activity: Q3 2025 in Review

8 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in BioVie Inc Warrant (BIVIW) for Q3 2025, worth a combined $734K.

Buyers outnumbered sellers: 8 funds opened new BIVIW positions and 0 closed out — a net gain of 8 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Diametric Capital, opening a new position worth an estimated $305K.

  • 8 institutional investors held BioVie Inc Warrant (BIVIW) as of Q3 2025, up from 0 in Q2 2025.
  • Funds reported $734K of BioVie Inc Warrant stock for Q3 2025.
  • 8 funds opened new BioVie Inc Warrant positions in Q3 2025 and 0 closed out, a net change of +8 holders.
  • The largest BioVie Inc Warrant buyer in Q3 2025 was Diametric Capital, an estimated $305K added.

Based on aggregated 13F filings for Q3 2025.